Walmsley’s GSK strategy revamp helps lift earnings
Drugmaker warns 2019 earnings likely to be hit by generic rival to Advair (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 6, 2019 Category: Pharmaceuticals Source Type: news
First Generic Version of Advair Diskus Approved for Asthma, COPD
Title: First Generic Version of Advair Diskus Approved for Asthma, COPDCategory: Health NewsCreated: 1/31/2019 12:00:00 AMLast Editorial Review: 2/1/2019 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 1, 2019 Category: Respiratory Medicine Source Type: news
FDA approves generic version of Advair Diskus for asthma, COPD
The U.S. Food and Drug Administration today approved the first generic form of the popular asthma inhaler Advair Diskus, according to the agency. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 31, 2019 Category: Consumer Health News Source Type: news
FDA Approves Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of Advair Diskus
HERTFORDSHIRE, England and PITTSBURGH, Jan. 31, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. Food and Drug Administration (FDA) approval of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 31, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Generic Version of Advair for Asthma, COPD
THURSDAY, Jan. 31, 2019 -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
The medication can now be used to treat children... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2019 Category: Pharmaceuticals Source Type: news
Mylan wins race for generic Advair approval
FDA has approved the first generic of GlaxoSmithKline‘s (NYSE:GSK) blockbuster Advair respiratory drug, this one by Mylan (NSDQ:MYL), six months after rejecting Mylan’s application.
Canonsburg, PA-based Mylan’s shares jumped 7% to $30.82 at market close after yesterday’s late-afternoon announcement, and were trading at $30.96 mid-morning today. GSK’s stock dipped 2% to$38.70 on the news late yesterday, but had more than recovered by noon today, reaching $39.23.
Get the full story on our sister site, Drug Delivery Business.
The post Mylan wins race for generic Advair approval appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Drug-Device Combinations Food & Drug Administration (FDA) Respiratory GlaxoSmithKline plc Mylan Novartis Source Type: news
Morning Break: Generic Advair; Polar Vortex Deaths; Valsartan Gouging
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 31, 2019 Category: Pediatrics Source Type: news
First Generic Version of Advair Diskus Approved for Asthma, COPD
THURSDAY, Jan. 31, 2019 -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
It can now be used to treat children aged 4 or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 31, 2019 Category: General Medicine Source Type: news
Generic Version of Popular Asthma Inhaler, Advair Diskus, Wins FDA Approval
THURSDAY, Jan. 31, 2019 -- The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval.
This approval " is part of our longstanding... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 31, 2019 Category: General Medicine Source Type: news
FDA approves first generic Advair Diskus
The U.S. Food and Drug Administration approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). (Source: World Pharma News)
Source: World Pharma News - January 31, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
FDA OKs 1st generic version of popular Advair asthma inhaler
First generic version of popular Advair asthma inhaler approved by US regulators (Source: ABC News: Health)
Source: ABC News: Health - January 30, 2019 Category: Consumer Health News Tags: Health Source Type: news
FDA Approves First Generic Advair Diskus
January 30, 2019 -- The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news
FDA Approves First Generic of Advair Diskus FDA Approves First Generic of Advair Diskus
The Mylan generic comes in three strengths and is indicated for twice-daily treatment of asthma in patients as young as age 4 and for adults with COPD.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news
FDA approves Mylan's generic of Advair asthma treatment
The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
FDA approves first generic Advair Diskus
FDA approved the first generic of Advair Diskus for treatment of asthma and maintenance treatment of airflow obstruction and reducing exacerbations with COPD. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 30, 2019 Category: American Health Source Type: news
